U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Reports, Manuals, & Forms
  4. Reports
  5. Economic Impact Analyses of FDA Regulations
  6. Summary: Sunlamp Products; Proposed Amendment to Performance Standard (Proposed Rule)
  1. Economic Impact Analyses of FDA Regulations

Summary: Sunlamp Products; Proposed Amendment to Performance Standard (Proposed Rule)

The proposed rule would address performance standards of sunlamp products and  ultraviolet (UV) lamps intended for use in these products. The proposed rule intends to reduce health risks associated with such use. 

The primary benefit of the proposed rule would be from reduced injuries, including sunburn, photokeratitis, skin cancer, cataracts and ocular melanoma,  and from reduced exposure to UV radiation. Cost are associated with several aspects of the performance standards, and we use ranges to capture uncertainty.

Regulatory Impact Analysis

Sunlamp Products; Proposed Amendment to Performance Standard (Proposed Rule) (PDF - 211KB)

Federal Register: 80 FR 79505, December 22, 2015

Docket:  FDA-1998-N-0880

   
Back to Top